US researchers create 16 new viruses using AI technology

In a significant scientific breakthrough, researchers in the United States have created 16 new viruses using artificial intelligence. This achievement, reported in the journal Science, involved generating thousands of genomes based on a naturally occurring phage and synthesizing nearly 300 of them in laboratory conditions. The synthetic viruses proved to be more effective at targeting E. coli bacteria than their natural counterparts, highlighting the potential for medical advancements while also raising concerns about the risks associated with AI technology in virus creation.

US researchers create 16 new viruses using AI technology
4 sources
science Published Aug 7, 2026

Topic overview

In brief

  • Researchers at Stanford University and the Broad Institute created 16 new viruses using AI technology.
  • The synthetic viruses were more effective at killing E. coli bacteria than naturally occurring viruses.
  • The study raises both hopes for medical advances and concerns about biosecurity risks.

Summary

In a groundbreaking study published in the journal Science, researchers from Stanford University and the Broad Institute of MIT and Harvard announced the creation of 16 new viruses using artificial intelligence. This innovative approach involved using a naturally occurring phage, a virus that infects bacteria, as a template to generate thousands of genomes through AI technology. The researchers chemically synthesized nearly 300 of these genomes and tested them in laboratory conditions, resulting in 16 viable synthetic viruses. Notably, these synthetic viruses demonstrated greater effectiveness in killing E. coli bacteria compared to their naturally occurring counterparts.

The implications of this research are significant, as it showcases the potential of generative models to capture evolutionary constraints in DNA sequences. The researchers emphasized that their method allows for the production of complete bacteriophage genomes that are divergent from those found in nature, with specific traits predetermined by the researchers. This advancement in synthetic genomics could pave the way for developing adaptive and resilient phage therapies to combat rapidly evolving pathogens, which is particularly relevant in the context of increasing antibiotic resistance.

Key entities

How Mestios works We aggregate coverage, extract key information, and use AI to summarize and compare perspectives. Learn more

Updated Aug 7, 2026

AI-generated summary. Please verify important information from original sources.